Radha Samtani, NP
Gerontology · Atlanta, GANPI 1144882044
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,036 of the $3,718 with a category attached, or 81.6%. 37 manufacturers reported payments, led by Merck at 26.7% of the total. 2025 is the largest year on record at $2,240, 9.7 times the $231 reported in 2022.
Across 110 payments — averaging $33.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$994
- Eisai Inc.$763
- AstraZeneca$424
- Johnson & Johnson$246
- Genentech USA, Inc.$177
- GSK$134
- plus $980 from 31 others
What the payments were for
- Consulting fees$68318%
- Food & beverage$3,03682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 14 | $994 |
| Eisai Inc. | 24 | $763 |
| AstraZeneca(2 entities) | 13 | $424 |
| Johnson & Johnson | 6 | $246 |
| Genentech USA, Inc. | 3 | $177 |
| GSK | 5 | $134 |
| Pfizer | 4 | $88 |
| Exelixis Inc. | 3 | $84 |
| Coherus Oncology, Inc. | 3 | $66 |
| Daiichi Sankyo Inc. | 3 | $60 |
| Servier Pharmaceuticals LLC | 2 | $50 |
| Novartis | 2 | $43 |
| AbbVie | 2 | $42 |
| Seagen Inc. | 2 | $41 |
| Incyte Corporation | 2 | $37 |
| Jazz Pharmaceuticals Inc. | 1 | $31 |
| Astellas Pharma US Inc | 1 | $29 |
| AVEO Pharmaceuticals, Inc. | 1 | $29 |
| Taiho Oncology, Inc. | 1 | $29 |
| Iovance Biotherapeutics, Inc. | 1 | $26 |
| Immunogen, Inc. | 1 | $26 |
| Stemline Therapeutics Inc. | 1 | $25 |
| EMD Serono, Inc. | 1 | $24 |
| Adaptive Biotechnologies Corporation | 1 | $23 |
| Acrotech Biopharma Inc. | 1 | $23 |
| Caris MPI, Inc. | 1 | $22 |
| Sobi, Inc | 1 | $21 |
| Agios Pharmaceuticals, Inc. | 1 | $20 |
| Beone Medicines USA, Inc. | 1 | $20 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
| Mimedx Group, Inc. | 1 | $17 |
| On Target Laboratories, Inc | 1 | $17 |
| Solventum Corporation | 1 | $16 |
| Baxter Healthcare | 1 | $15 |
| Geron Corporation | 1 | $14 |
| Bayer | 1 | $12 |
| Pharmaand GmbH | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,718 in reported general payments places this provider in the 85th percentile of 197 gerontology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 29 | $19,280 |
| Duloxetine Hcl | 14 | $304 |
| Ondansetron Hcl | 21 | $256 |
| Gabapentin | 23 | $225 |
| Dexamethasone | 25 | $184 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $107 |
| Neomycin Sulfate | 19 | $102 |
| Metronidazole | 18 | $25 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $88 | $19,28029 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 197 gerontology providers in Georgia.
Other gerontology in Atlanta
- Carolyn ClevengerAtlanta$65K
- Mitzi LewisAtlanta$37K
- Constance MeinkenAtlanta$36K
- Kathleen BradfordAtlanta$8K
- Virginia KeatingAtlanta$5K
- Robin BrownAtlanta$5K
- Julia VargheseAtlanta$4K
- Mirali PatelAtlanta$4K
- Brittany HaynesAtlanta$3K
- Victoria HutsonAtlanta$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.